We discuss here critical factors in ensuring the success of a viral diagnostic at the point of care. Molecular and immunoassay approaches are reviewed with a focus on their ability to meet the ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Changes in healthcare economics are clearly having an impact on point-of-care (POC) diagnostic testing. Market demand for remote testing is driving companies to develop easy-to-use platforms versus ...

Pricing pressure due to reimbursement cuts and limited budgets along with strict regulatory approval process for new point of care product commercialization are factors expected to restrain market ...

The development of new tests to address new diseases, or those that previously had no useful biomarker, is stimulating IVD growth. It is interesting that many of these new analytes are almost ...

Point-of-care testing refers to diagnostic procedures conducted near the patient or at the site of care, outside of ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

Selbyville, Delaware, United States, October 23 2020 (Wiredrelease) Global Market Insights, Inc –:The point of care molecular (POC) diagnostics market is poised for robust growth on the back of the ...

DUBLIN--(BUSINESS WIRE)--The "Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform ...